Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD

被引:29
作者
de Masson, Adele [1 ,2 ]
Bouaziz, Jean-David [1 ,2 ]
de Latour, Regis Peffault [3 ]
Wittnebei, Sebastian [4 ]
Ribaud, Patricia [3 ]
Rubio, Marie-Therese [5 ]
Micol, Jean-Baptiste [4 ]
Suarez, Felipe [6 ]
Nguyen, Stephanie [7 ]
Dalle, Jean-Hugues [8 ]
Yakouben, Karima [8 ]
Robin, Marie [3 ]
Xhaard, Alienor [3 ]
Ades, Lionel [3 ]
Bourhis, Jean-Henri [4 ]
Rybojad, Michel [1 ,2 ]
Bagot, Martine [1 ,2 ]
Socie, Gerard [3 ]
机构
[1] Univ Paris 07, Hop St Louis, AP HP, Serv Dermatol, F-75010 Paris, France
[2] Univ Paris 07, Hop St Louis, Lab Immunol Dermatol & Oncol, UMR S 976, F-75010 Paris, France
[3] Hop St Louis, Serv Hematol Greffe, Paris, France
[4] Inst Gustave Roussy, Serv Hematol Oncol, Villejuif, France
[5] Hop St Antoine, Serv Hematol & Therapie Cellulaire, F-75571 Paris, France
[6] Hop Necker Enfants Malad, Serv Hematol Adultes, Paris, France
[7] Hop La Pitie Salpetriere, Serv Hematol, Paris, France
[8] Hop Robert Debre, Serv Hematol Immunol Pediat, F-75019 Paris, France
关键词
VERSUS-HOST-DISEASE;
D O I
10.1182/blood-2012-09-453928
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:5089 / 5090
页数:2
相关论文
共 6 条
[1]   A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies [J].
Chen, George L. ;
Arai, Sally ;
Flowers, Mary E. D. ;
Otani, Joanne M. ;
Qiu, Jingxin ;
Cheng, Ethan C. ;
McMillan, Alex ;
Johnston, Laura J. ;
Shizuru, Judith A. ;
Miklos, David B. .
BLOOD, 2011, 118 (15) :4070-4078
[2]   National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report [J].
Filipovich, AH ;
Weisdorf, D ;
Pavletic, S ;
Socie, G ;
Wingard, JR ;
Lee, SJ ;
Martin, P ;
Chien, J ;
Przepiorka, D ;
Couriel, D ;
Cowen, EW ;
Dinndorf, P ;
Farrell, A ;
Hartzman, R ;
Henslee-Downey, J ;
Jacobsohn, D ;
McDonald, G ;
Mittleman, B ;
Rizzo, JD ;
Robinson, M ;
Schubert, M ;
Schultz, K ;
Shulman, H ;
Turner, M ;
Vogelsang, G ;
Flowers, MED .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (12) :945-956
[3]   Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium [J].
Jacobsohn, David A. ;
Kurland, Brenda F. ;
Pidala, Joseph ;
Inamoto, Yoshihiro ;
Chai, Xiaoyu ;
Palmer, Jeanne M. ;
Arai, Sally ;
Arora, Mukta ;
Jagasia, Madan ;
Cutler, Corey ;
Weisdorf, Daniel ;
Martin, Paul J. ;
Pavletic, Steven Z. ;
Vogelsang, Georgia ;
Lee, Stephanie J. ;
Flowers, Mary E. D. .
BLOOD, 2012, 120 (13) :2545-2552
[4]   Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease [J].
Magro, Leonardo ;
Mohty, Mohamad ;
Catteau, Benoit ;
Coiteux, Valerie ;
Chevallier, Patrice ;
Terriou, Louis ;
Jouet, Jean-Pierre ;
Yakoub-Agha, Ibrahim .
BLOOD, 2009, 114 (03) :719-722
[5]   Imatinib for refractory chronic graft-versus-host disease with fibrotic features [J].
Olivieri, Attilio ;
Locatelli, Franco ;
Zecca, Marco ;
Sanna, Adele ;
Cimminiello, Michele ;
Raimondi, Roberto ;
Gini, Guido ;
Mordini, Nicola ;
Balduzzi, Adriana ;
Leoni, Pietro ;
Gabrielli, Armando ;
Bacigalupo, Andrea .
BLOOD, 2009, 114 (03) :709-718
[6]   Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease [J].
Svegliati, Silvia ;
Olivieri, Attilio ;
Campelli, Nadia ;
Luchetti, Michele ;
Poloni, Antonella ;
Trappolini, Silvia ;
Moroncini, Gianluca ;
Bacigalupo, Andrea ;
Leoni, Pietro ;
Avvedimento, Enrico V. ;
Gabrielli, Armando .
BLOOD, 2007, 110 (01) :237-241